The PsyWell study: promoting Psychological Wellbeing using an internet-based training programme

ISRCTN ISRCTN48134476
DOI https://doi.org/10.1186/ISRCTN48134476
Secondary identifying numbers N/A
Submission date
19/04/2010
Registration date
27/05/2010
Last edited
11/01/2013
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English Summary

Not provided at time of registration

Study website

Contact information

Dr John Powell
Scientific

Health Sciences Research Institute
Warwick Medical School
Gibbet Hill Road
Coventry
CV4 7AL
United Kingdom

Study information

Study designRandomised controlled trial with two arms: intervention and waiting-list control
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Other
Study typeTreatment
Participant information sheet Please use the contact details below to request a patient information sheet
Scientific titleThe PsyWell study: A randomised controlled trial of an internet-based cognitive behaviour therapy based training programme to improve psychological wellbeing
Study acronymPSYWELL
Study hypothesisA self-delivered online CBT-based training programme can promote mental wellbeing in the general population
Ethics approval(s)The Black Country NHS Research Ethics Committee (NRES) approved in March 2010 (ref: 10/H1202/21)
ConditionMental wellbeing
InterventionIntervention group receive access to MoodGYM. MoodGYM is a 5 week program comprising of 5 interactive modules, a series of quizzes and 29 exercises. The modules provide training in techniques of cognitive therapy (cognitive restructuring), behavioural methods for overcoming dysfunctional thinking, relaxation, problem solving, assertiveness and self-esteem training, and strategies for coping with relationship break-up. The ‘quizzes’ include a series of anxiety and depression scales (that permit the user to track the change in their symptoms across modules) and a range of other measures (such as quizzes which assist the user to understand their particular profile of thinking patterns or to identify their preferred and actual pleasant events profile). Feedback on the quizzes is based on normative data collected from large scale epidemiological surveys. Users can consult their workbook containing completed exercises at any time. At the end of each module, the user can, if they wish, print out a summary of their session, including the level of their depressive and anxiety symptoms, their scores on other tasks, their goals and achievements. This summary is written in a format that is intended to be taken to the person’s health practitioner should this be deemed appropriate by the user. The user is provided with a personalised certificate of completion at the end of the five modules.
Participants in the intervention arm will receive weekly email reminders to log into the trial portal where they can access the intervention.

Comparison group is a waiting list control who will receive access to MoodGYM after 3 months.
Intervention typeOther
Primary outcome measureMental wellbeing, comparing changes from baseline to follow-up at 6 weeks and 3 months. This will be measured using the 14-item Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS).

Additional information added as of 08/12/2010:
Updated prior to final outcome measures being measured in the trial to give additional information on ISRCTN, as advised by our steering group. No changes made to original plans, just further information for the purposes of providing full information and clarity.

The primary outcome will be changes from baseline on the WEMWBS mental wellbeing scale, comparing the repeated measures (6 weeks, and 12 weeks) between the two groups. We will use mixed-model repeated-measures ANOVA with measurement occasion as a within-groups factor and intervention as a between-groups factor. We will compare changes from baseline in each group at 6-weeks post-test, and 12 week follow-up. We will use the 14-item Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS).

Co-variates are: age, sex, educational level, employment status, ethnic group, baseline marital status, baseline general health, baseline smoking status, baseline mental health scores, baseline physical activity, baseline alcohol use, baseline drug use, previous mental health service use, previous internet use and experience, previous experience of CBT, previous experience of internet-based CBT.
Secondary outcome measuresThe following measured at 6 weeks and 3 months:
1. Depression (CES-D)
2. Anxiety (GAD-7)
3. Quality of life (EQ5D)
4. Physical activity (self-report)
5. Health service use (self-report)

Additional information added as of 08/12/2010:
Updated prior to final outcome measures being measured in the trial to give additional information on ISRCTN, as advised by our steering group. No changes made to original plans, just further information for the purposes of providing full information and clarity.

Secondary outcomes will be changes from baseline for depression scores, anxiety scores, quality of life measurement, and for physical activity, and for health service use, measured at baseline and 12 weeks. We are measuring these using the CES-D (depression), GAD-7 (anxiety), EQ5D (quality of life), the single-item measure of physical activity, and self-report of health service use of number of attendances in primary care, secondary care outpatients, and secondary care inpatient stays. We will also compare self-rated general health.

Co-variates are: age, sex, educational level, employment status, ethnic group, baseline marital status, baseline general health, baseline smoking status, baseline mental health scores, baseline physical activity, baseline alcohol use, baseline drug use, previous mental health service use, previous internet use and experience, previous experience of CBT, previous experience of internet-based CBT.

We will also undertake the following pre-specified sub-group analyses, comparing primary and secondary outcome measures for the following subgroups:
1. Age groups: we have an a priori hypothesis that MoodGYM may be of more benefit to a young age group as it was originally developed for this group. We will therefore undertake a subgroup analysis for the age group aged 25 and younger (and compare with the group aged over 25).
2. Gender: male and female. There is some research to suggest gender differences in mental wellbeing and in response to psychological intervention. We will therefore undertake a subgroup analysis by gender (male and female subgroups).
3. Educational level: as this is an information based intervention it is possible that those with a higher level of education and literacy may do better. We will therefore analyse subgroups by educational level. We will analyse two subgroups:
3.1. Those with a degree level qualification or higher
3.2. Those without
4. Previous psychiatric history: we will compare those who have previously received treatment for a mental health problem to those without this history.
5. Previous experience of cognitive behavioural therapy: we will compare those with previous experience of cognitive behavioural therapy to those without.
6. Depression: we will compare those who are indicated to have depression at baseline (using CES-D), to those who do not.
7. Anxiety: we will compare those who are indicated to have anxiety at baseline (using GAD-7) to those who do not.
Overall study start date01/06/2010
Overall study end date31/12/2010

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants2040
Participant inclusion criteria1. Adults aged 18 or over
2. Located in England
3. Able to read and write English
4. Have access to the internet in order to use the intervention
5. Have an email address where they can be contacted
6. Give informed consent
Participant exclusion criteria1. Aged under 18
2. Located outside England
3. Unable to read and write English
4. Unable to access the intervention
5. No email address provided
6. Email address has already been registered as a trial participant
7. No consent given
Recruitment start date01/06/2010
Recruitment end date31/12/2010

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Health Sciences Research Institute
Coventry
CV4 7AL
United Kingdom

Sponsor information

University of Warwick (UK)
University/education

University House
Kirby Corner Road
Coventry
CV4 8UW
England
United Kingdom

Website http://www2.warwick.ac.uk/services/rss/
ROR logo "ROR" https://ror.org/01a77tt86

Funders

Funder type

Government

Department of Health/NHS Choices (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 31/12/2012 Yes No